Kythera Chops 117 Employees In Post Acquisition Layoff

In a blow to the biopharmaceuticals industry along the 101 corridor, Westlake Village-based aesthetic medicine developer Kythera Biopharmaceuticals disclosed on Tuesday that it is laying off 117 of its employees, just days after the consummation of a deal to be acquired by Allergan. The $2.1 billion cash acquisition of Kythera by Allergan closed on October 1st. The layoffs number to more than half of the company's pre-acquisition workforce, of around 200 employees earlier this year.